IN-DATE
5833690: Bard HemoStar Dialysis Catheter, Straight 14.5F x 19cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $46.50 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 04-2027 |
Additional Details
HemoStar Dialysis Catheter
5833690
- Straight, Standard Kit
- Catheter Size: 14.5F
- Insertion Length (Tip to Cuff): 19cm
- Catheter Length: 24cm
- Tip Style: Staggered
Features
- Polyurethane catheter material
- Large lumens and non-restrictive tip design
- Exceptional kink resistance
- Guidewire channel
- Malleable tunneler
- AirGuard® valved introducer
AccessGUDID Info
- FDA Product Code: MSD
- FDA Product Code Name: Catheter, hemodialysis, implanted
- GMDN Term Code: 37278
- GMDN Term Name: Double-lumen haemodialysis catheter, implantable
- GMDN Term Description: An implantable, flexible, double-lumen tube intended to be used for chronic or long-term (> 30 days) vascular access, primarily during haemodialysis, to conduct blood from a patient and returning it after extracorporeal circulation; it may also be used during haemoperfusion and/or apheresis. It is intended for coaxial flow of blood, may be radiopaque, coated with heparin to prevent thrombus formation, and/or include a silver-coated sleeve to retard bacterial growth; devices dedicated to catheter introduction/function (e.g., introducer needle) may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
